Latest On-Demand Webinars & Online Events

In this webinar, Dr. Mark Pandori will join us to delve into the use of advanced molecular techniques, particularly DNA and RNA-based methods, to detect infectious agents in clinical specimens. We will explore how these innovative technologies, inclu

Join experts Dr. Tania Nolan and Prof. Steven Bustin in the final episode of the New Frontiers in PCR Technology series. Learn best practices, common qPCR pitfalls and ensure reproducibility and rigor in your molecular research.

Explore the New Frontiers in PCR Technology Series 2024! Join us for three episodes featuring experts discussing advancements in PCR, automation, digital PCR and qPCR. Engage with speakers through live Q&As and stay ahead in genetic analysis.

Technological advances in molecular biology have revolutionized the management of cancer patients, and also assisted their relatives in cases of genetic predisposition identification.

Combining isothermal amplification and lateral flow technologies (IA-LFA) creates a powerful diagnostic tool that provides the sensitivity and specificity of isothermal amplification, with the rapid read out results of lateral flow assays.

In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.

As we advance through 2024, significant updates in Human Immunodeficiency Virus (HIV) and Sexually Transmitted Infections (STI) prevention and treatment are emerging. How will these developments shape future strategies in HIV and STI management?

Recent years have witnessed a sea-change in how laboratory tests have been employed to diagnose, monitor, and manage viral infections.

In this webinar, Dr. James Dunn will join us to discuss the process for the practical implementation of multiplex molecular assays for infectious diseases at different points of service.

In recent past respiratory seasons, the world witnessed a “tripledemic” of Influenza (flu), SARS-CoV-2 (COVID-19), and Respiratory Syncytial Virus (RSV). The 2024-25 landscape will likely be different, with new virus variants, new vaccines and treatments, like the game-changing antibody that protects children from RSV. The healthcare and public health community have also learned some valuable lessons going forward with the ever-evolving respiratory agents.

In this presentation, Dr. Rodney Rohde will discuss the primary microbiology, epidemiology, control, prevention, vulnerable populations, the importance of laboratory validation, and the benefits of molecular-based testing of these three primary respiratory season pathogens.